Treatment of Bilateral Retinal Angiomatous Proliferation with Anti-vascular Endothelial Growth Factor: 12-Month Outcome.

about

Treatment of Bilateral Retinal Angiomatous Proliferation with Anti-vascular Endothelial Growth Factor: 12-Month Outcome.

Item

http://www.wikidata.org/entity/Q42204337

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Treatment of Bilateral Retinal ...... owth Factor: 12-Month Outcome.

@en

Treatment of Bilateral Retinal ...... owth Factor: 12-Month Outcome.

@nl

type

Item

label

Treatment of Bilateral Retinal ...... owth Factor: 12-Month Outcome.

@en

Treatment of Bilateral Retinal ...... owth Factor: 12-Month Outcome.

@nl

prefLabel

Treatment of Bilateral Retinal ...... owth Factor: 12-Month Outcome.

@en

Treatment of Bilateral Retinal ...... owth Factor: 12-Month Outcome.

@nl

P1476

Treatment of Bilateral Retinal ...... owth Factor: 12-Month Outcome.

@en

P2093

Chul Gu Kim

http://www.w3.org/2001/XMLSchema#string

Dong Won Lee

http://www.w3.org/2001/XMLSchema#string

Jae Hui Kim

http://www.w3.org/2001/XMLSchema#string

Jae Min Kim

http://www.w3.org/2001/XMLSchema#string

Jong Woo Kim

http://www.w3.org/2001/XMLSchema#string

Young Suk Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

Ranibizumab for neovascular age-related macular degeneration

Prevalence of reticular pseudodrusen in age-related macular degeneration with newly diagnosed choroidal neovascularisation.

Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation.

Retinal angiomatous proliferation in age-related macular degeneration.

Intravitreal anti-vascular endothelial growth factor for typical exudative age-related macular degeneration in eyes with good baseline visual acuity.

Choroidal thickness in patients with reticular pseudodrusen using 3D 1060-nm OCT maps.

Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration.

The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy

Retinal angiomatous proliferation and intravitreal bevacizumab injection.

P304

240-248

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3341/KJO.2016.0026

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28471100

http://www.w3.org/2001/XMLSchema#string

P921

endothelium

P932

5469927

http://www.w3.org/2001/XMLSchema#string